跳至主要内容
临床试验/JPRN-UMIN000003628
JPRN-UMIN000003628尚未招募未知

Toyama Anti-arteriosclerosis and Plaque Assessment Trial by Aggressive Lipid Lowering Therapy with Pitavastatin in Peripheral Artery Disease - TULIP

The Second Department of Internal Medicine, University of Toyama, Graduate school of medicine and pharmaceutical science,0 个研究点目标入组 50 人开始时间: 2010年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Following "contraindication" or "essentially contraindication" of pitavastatin as follows: severe liver injury or biliary obstruction patients taking cyclosporin pregnant or possible pregnant women or breast-feeding women patients with renal dysfunction and taking fibrates 2) patients already taking pitavastatin 3) patients with maintenance dialysis 4) patients who plan to undergo or underwent bilateral lower limb revascularization within within 3 months. 5) patients with severe peripheral artery disease (Fontaine classification class 4) 6) patient with previous cerebral hemorrhage 7) patients who judged inadequate by the co-execution doctor

研究者

发起方
The Second Department of Internal Medicine, University of Toyama, Graduate school of medicine and pharmaceutical science,

相似试验